Regeneron Pharmaceuticals, Inc. Financial Ratios — REGN34

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-43.76	86.68	25.88	15.02	20.5	22.1	22.63	32.81	21.32	31.77	54.21	20.94	16.26	15.95	14.87
Return on Assets (%)	-18.38	44.08	16.45	9.96	13.47	14.23	15.23	23.85	15.94	21.98	37.91	15.88	12.69	12.46	11.5
Return on Capital (%)	- -	- -	21.22	12.98	18.32	20.12	20.6	30.3	20.14	27.94	46.18	18.75	14.89	14.7	13.76
Return on Invested Capital (%)	- -	- -	21.22	13.39	18.5	19.51	19.96	29.71	18.04	25.77	43.6	17.94	14.1	12.09	9.26
Gross Margin (%)	99.05	93.87	92.62	92.73	90.43	93.83	93.24	91.89	88.33	86.82	84.83	87.18	86.16	86.13	85.35
EBITDA Margin (%)	-39.05	35.88	37.26	31.09	32.33	29.53	37.89	52.13	36.91	44.87	57.45	41.73	34.06	31.5	28.74
Operating Margin (%)	-46.02	33.2	35.3	29.22	30.51	27.38	35.41	49.25	33.7	42.09	55.97	38.93	30.85	28.1	25.81
Incremental Operating Margin (%)	812.73	71.07	39.29	11.31	33.33	10.41	74.02	- -	- -	70.47	71.53	109.16	- -	- -	- -
Pretax Margin (%)	-50	30.06	33.09	27	29.85	27.36	35.4	49.62	37.04	44.84	58.03	39.91	32.01	33.66	36.47
Profit Margin (%)	-49.74	54.43	19.66	11.99	15.5	18.42	20.41	47.5	32.26	41.35	50.25	35.64	30.14	31.07	31.41
Net Income to Common Margin (%)	-49.74	54.43	19.66	11.99	15.5	18.42	20.41	47.5	32.26	41.35	50.25	35.64	30.14	31.07	31.41
Effective Tax Rate (%)	- -	- -	40.59	55.58	48.08	32.66	42.34	4.27	12.9	7.8	13.41	10.71	5.85	7.68	13.88
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.22
Sustainable Growth Rate (%)	-43.76	86.68	25.88	15.02	20.5	22.1	22.63	32.81	21.32	31.77	54.21	20.94	16.26	15.95	13.64

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	436	457	506	458	363	481	704	709	714	2,696	2,700	2,701	2,703	2,704	2,706
ST Debt	1	1	1	- -	- -	130	- -	- -	- -	- -	720	- -	- -	- -	- -
LT Debt	435	456	505	458	363	352	704	709	714	2,696	1,980	2,701	2,703	2,704	2,706
Total Debt/EBITDA	-2.5	0.92	0.64	0.52	0.27	0.34	0.32	0.26	0.29	0.71	0.29	0.53	0.6	0.6	0.66
Net Debt/EBITDA	1.2	0.13	-0.27	-0.57	-0.61	-0.37	-0.37	-0.55	-0.67	-0.06	-0.1	-0.22	-0.17	-0.11	-0.27
Total Debt/EBIT	-2.12	1	0.68	0.56	0.29	0.36	0.34	0.28	0.32	0.75	0.3	0.57	0.67	0.68	0.76
Net Debt/EBIT	1.02	0.14	-0.29	-0.61	-0.65	-0.4	-0.39	-0.58	-0.73	-0.06	-0.1	-0.24	-0.18	-0.13	-0.32
EBITDA to Interest Expense	-8.18	10.92	16.89	23.46	93.17	199.36	88.65	95.13	80.14	67	161.13	85.53	61.21	81.04	94.1
EBITDA-CapEx/Interest Expense	-8.18	10.92	16.89	23.46	93.17	199.36	88.65	95.13	80.14	67	161.13	68.24	58.36	78.77	86.9
EBIT to Interest Expense	-9.64	10.1	16	22.05	87.91	184.82	82.85	89.87	73.17	62.86	156.98	79.78	55.44	72.3	84.52
Interest Expense	21	45	46	37	14	7	25	28	30	57	57	59	73	55	44
Common Equity/Total Assets	36.7	59.86	66.15	66.45	65.16	63.8	70.1	74.63	74.9	64.24	73.79	77.58	78.52	77.74	77.07
Long-Term Debt/Equity (%)	89.46	36.61	25.85	17.95	9.93	7.9	11.45	8.09	6.44	24.45	10.55	11.92	10.41	9.21	8.66
Long-Term Debt/Capital (%)	47.17	26.78	20.53	15.22	9.03	7.13	10.27	7.48	6.05	19.65	9.22	10.65	9.43	8.44	7.97
Long-Term Debt/Total Assets (%)	32.83	21.92	17.1	11.93	6.47	5.04	8.03	6.04	4.82	15.71	7.78	9.25	8.17	7.16	6.67
Total Debt/Equity (%)	89.67	36.72	25.9	17.95	9.93	10.81	11.45	8.09	6.44	24.45	14.38	11.92	10.41	9.21	8.66
Total Debt/Capital (%)	47.28	26.86	20.57	15.22	9.03	9.76	10.27	7.48	6.05	19.65	12.58	10.65	9.43	8.44	7.97
Total Debt/Total Assets (%)	32.91	21.98	17.13	11.93	6.47	6.9	8.03	6.04	4.82	15.71	10.61	9.25	8.17	7.16	6.67
Net Debt to Equity	-42.94	5.32	-11.03	-19.68	-22.14	-12.03	-13.23	-16.76	-14.59	-1.95	-4.83	-4.96	-2.88	-1.72	-3.62
Net Debt/Capital (%)	-47.66	4.5	-11.2	-21.28	-25.22	-12.18	-13.47	-18.35	-15.88	-1.87	-4.87	-5.05	-2.88	-1.7	-3.67
EBITDA	-174	495	784	877	1,327	1,435	2,225	2,683	2,420	3,813	9,233	5,080	4,468	4,474	4,122
EBITDA-CapEx	-174	495	784	877	1,327	1,435	2,225	2,683	2,420	3,813	9,233	4,054	4,260	4,348	3,806
Operating Income (Loss)	-205	458	743	824	1,252	1,331	2,080	2,534	2,210	3,577	8,995	4,739	4,047	3,991	3,702

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.55	1.88	2.32	1.38	1.29	0.84	1.24	1.95	1.53	1.33	1.45	2.46	3.17	2.28	1.97
Current Ratio	4.49	7.37	6.01	3.18	3.59	2.56	3.82	4.47	3.67	3.63	3.56	5.06	5.69	4.73	4.13
Quick Ratio	4.25	6.12	5.52	2.87	3.1	2.13	2.98	3.5	2.86	2.86	2.98	4.16	4.82	3.86	3.28
CFO/Avg Current Liab	-1.1	-0.48	2.55	1.58	1.82	1.45	1.1	1.7	1.37	1.09	2.14	1.42	1.4	1.2	1.2
Common Equity/Total Assets	36.7	59.86	66.15	66.45	65.16	63.8	70.1	74.63	74.9	64.24	73.79	77.58	78.52	77.74	77.07
Long-Term Debt/Equity (%)	89.46	36.61	25.85	17.95	9.93	7.9	11.45	8.09	6.44	24.45	10.55	11.92	10.41	9.21	8.66
Long-Term Debt/Capital (%)	47.17	26.78	20.53	15.22	9.03	7.13	10.27	7.48	6.05	19.65	9.22	10.65	9.43	8.44	7.97
Long-Term Debt/Total Assets (%)	32.83	21.92	17.1	11.93	6.47	5.04	8.03	6.04	4.82	15.71	7.78	9.25	8.17	7.16	6.67
Total Debt/Equity (%)	89.67	36.72	25.9	17.95	9.93	10.81	11.45	8.09	6.44	24.45	14.38	11.92	10.41	9.21	8.66
Total Debt/Capital (%)	47.28	26.86	20.57	15.22	9.03	9.76	10.27	7.48	6.05	19.65	12.58	10.65	9.43	8.44	7.97
Total Debt/Total Assets (%)	32.91	21.98	17.13	11.93	6.47	6.9	8.03	6.04	4.82	15.71	10.61	9.25	8.17	7.16	6.67
CFO/Total Liabilities	-16.91	-8.93	58.92	58.45	68.1	58.87	49.89	73.73	65.4	42.65	106.23	76.56	64.64	52.59	53.53
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.88	22.11	35.17	15.79
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	8.66	7.6	9.59	9.87	10.48	7.99	7.68

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.82	3.46	2.55	2.92	3.36	3.16	3.28	2.44	2.85	2.62	3.17	2.14	2.39	2.39	2.4
Days Sales Outstanding	75.71	105.4	142.9	125.01	108.7	115.63	111.45	149.58	128.13	139.08	115.27	170.39	152.99	152.65	152.09
Inventory Turnover	0.47	3.73	3.14	2.06	2.14	0.94	0.71	0.44	0.6	0.67	1.26	0.72	0.73	0.7	0.67
Days Inventory Outstanding	780.78	97.79	116.29	177.33	170.76	388.46	517.24	820.62	612.24	543	289.6	509.14	500.76	524.93	546.28
Accounts Payable Turnover	0.9	2.89	3.91	3.26	4.18	3.34	4.62	4.25	3.24	3.63	4.76	3.49	3.34	3.55	2.56
Accounts Payable Turnover Days	407.42	126.11	93.41	111.81	87.35	109.36	78.96	85.86	112.81	100.61	76.74	104.65	109.42	102.85	142.47
Cash Conversion Cycle	449.07	77.08	165.78	190.54	192.11	394.73	549.72	884.34	627.55	581.47	328.13	574.87	544.33	574.73	555.91
Inventory to Cash Days	-705.07	7.62	26.61	-52.33	-62.06	-272.84	-405.79	-671.03	-484.11	-403.93	-174.33	-338.75	-347.78	-372.28	-394.19
Inventories	17	29	70	129	239	399	726	1,151	1,416	1,917	1,951	2,402	2,581	3,087	3,201
Raw Materials	5	5	9	11	59	92	190	227	216	459	722	818	789	880	642
Work In Process	9	15	36	74	132	202	302	571	728	905	707	963	1,122	1,342	1,642
Finished Goods	1	3	14	11	11	13	22	24	71	122	74	99	147	140	190
Other Inventory	2	7	11	34	36	91	212	329	401	431	449	522	522	726	728

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	40,717	51,485	69,617	78,528	93,085	77,710	82,284
- Cash & Cash Equivalents	484	230	536	649	809	535	813	1,468	1,618	2,194	2,886	3,106	2,730	2,488	3,118
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	436	457	506	458	363	481	704	709	714	2,696	2,700	2,701	2,703	2,704	2,706
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	38,217	50,593	66,622	73,488	84,943	71,402	76,384
Total Capital	921	1,703	2,458	3,008	4,018	4,930	6,848	9,466	11,804	13,721	21,469	25,365	28,676	32,058	33,963
Total Debt/Capital (%)	47.28	26.86	20.57	15.22	9.03	9.76	10.27	7.48	6.05	19.65	12.58	10.65	9.43	8.44	7.97
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.02	0.05	0.04	0.04	0.03	0.04	0.04
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	5.83	5.95	4.15	6.04	6.48	5.03	5.33
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	15.79	13.27	7.22	14.47	19.01	15.96	18.53
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	17.29	14.15	7.45	15.51	20.99	17.89	21.35
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	15.56	18.94	9.34	14.5	18.22	15.97	15.23
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	15.56	18.94	9.34	18.18	19.07	16.43	16.25
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	42,313	55,407	71,875	81,323	96,727	81,597	84,527
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	39,813	54,516	68,880	76,282	88,585	75,289	78,628
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	5.76	7.87	10.2	11.15	12.91	10.83	12.02
TTM Sales	446	1,378	2,105	2,820	4,104	4,860	5,872	5,146	6,558	8,497	16,072	12,173	13,117	14,202	14,343
TTM EBITDA	-174	495	784	877	1,327	1,435	2,225	2,683	2,420	3,813	9,233	5,080	4,468	4,474	4,122
TTM Operating Income	-205	458	743	824	1,252	1,331	2,080	2,534	2,210	3,577	8,995	4,739	4,047	3,991	3,702
TTM Cash Flow to Firm	- -	- -	616	769	1,338	1,491	1,322	2,222	2,456	2,671	7,131	5,068	4,663	4,471	5,017
TTM Free Cash Flow to Firm	- -	- -	616	769	1,338	1,491	1,322	2,222	2,456	2,671	7,131	4,041	4,455	4,346	4,701

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	17.41	21.16	10.15	20.39	22.05	19	18.12
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	17.29	14.15	7.45	15.51	20.99	17.89	21.35
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	38,217	50,593	66,622	73,488	84,943	71,402	76,384
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	4.59	6.65	7.21	9.13	11.42	11.79	8.03
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	5.83	5.95	4.15	6.04	6.48	5.03	5.33
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	15.79	13.27	7.22	14.47	19.01	15.96	18.53
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	19.06	14.74	8.39	17.69	22.96	17.34	18.07
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	16.9	17.32	7.29	16.24	21.25	23.92	14.47
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	19.32	20.34	8.99	19.05	23.77	29.43	18.55
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	14.23	12.25	5.67	13.54	18.52	17.34	11.2
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	3.67	4.67	3.71	3.46	3.58	2.65	2.63
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	3.26	5.49	3.22	3.18	3.32	3.65	2.11
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	3.72	6.44	3.98	3.73	3.71	4.49	2.7
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	2.74	3.88	2.51	2.65	2.89	2.65	1.63
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	3.67	4.67	3.71	3.61	3.73	2.76	2.74
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	3.26	5.49	3.22	3.32	3.45	3.8	2.2
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	3.72	6.44	3.98	3.89	3.86	4.68	2.82
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	2.74	3.88	2.51	2.76	3.01	2.76	1.7
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	6.15	6.1	4.21	6.3	6.92	5.39	5.68
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	5.45	7.16	3.66	5.79	6.4	7.43	4.55
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	6.23	8.41	4.52	6.79	7.16	9.14	5.83
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	4.59	5.06	2.85	4.83	5.58	5.39	3.52
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	16.59	19.78	9.56	15.3	19.76	17.3	16.35
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	14.72	23.24	8.31	14.05	18.28	23.88	13.09
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	16.83	27.29	10.26	16.48	20.45	29.37	16.78
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	12.39	16.43	6.47	11.72	15.94	17.3	10.14
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	15.45	24.86	8.82	18.72	20.41	26.22	14.51
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	17.66	29.19	10.89	21.96	22.83	32.25	18.6
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	13	17.58	6.86	15.61	17.79	19	11.24
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	5.13	7.01	3.58	5.51	5.95	7.11	4.18
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	5.92	8.25	4.46	6.53	6.73	8.84	5.48
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	4.26	4.93	2.74	4.53	5.1	5.03	3.14
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	13.89	15.63	6.23	13.2	17.46	22.56	14.56
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	16.03	18.39	7.76	15.65	19.74	28.08	19.06
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	11.53	10.98	4.77	10.84	14.98	15.96	10.94
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	15.21	16.66	6.43	14.15	19.27	25.29	16.77
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	17.55	19.61	8.01	16.78	21.8	31.48	21.95
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	12.63	11.71	4.93	11.62	16.54	17.89	12.61
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	6.14	8.01	10.66	11.92	14.15	11.79	12.95
High Price	- -	- -	- -	- -	- -	- -	- -	- -	6.23	11.05	11.43	12.83	14.65	20.02	13.29
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	33,619	59,590	57,502	67,062	77,993	100,939	59,992
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	38,789	70,129	71,673	79,519	88,222	125,608	78,552
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	27,909	41,870	44,086	55,085	66,948	71,402	45,108

Shares Outstanding	5,579	5,849	5,993	6,158	6,291	6,373	6,470	6,553	6,630	6,430	6,533	6,589	6,578	6,590	6,355
Diluted Weighted Avg Shares	5,447	6,937	6,691	6,818	6,927	6,996	6,971	6,902	6,889	6,920	6,745	6,823	6,835	6,920	6,529
Basic Weighted Avg Shares	5,447	5,692	5,887	6,049	6,196	6,295	6,393	6,487	6,565	6,469	6,354	6,439	6,415	6,487	6,288
Revenue per Share	0.08	0.24	0.36	0.47	0.66	0.77	0.92	0.79	1	1.31	2.53	1.89	2.04	2.19	2.28
EBITDA per Share	-0.03	0.09	0.13	0.14	0.21	0.23	0.35	0.41	0.37	0.59	1.45	0.79	0.7	0.69	0.66
Operating Income per Share	-0.04	0.08	0.13	0.14	0.2	0.21	0.33	0.39	0.34	0.55	1.42	0.74	0.63	0.62	0.59
Basic EPS, GAAP	-0.04	0.13	0.07	0.06	0.1	0.14	0.19	0.38	0.32	0.54	1.27	0.67	0.62	0.68	0.72
Basic EPS from Cont Ops	-0.04	0.13	0.07	0.06	0.1	0.14	0.19	0.38	0.32	0.54	1.27	0.67	0.62	0.68	0.72
Diluted EPS, GAAP	-0.04	0.11	0.06	0.05	0.09	0.13	0.17	0.35	0.31	0.51	1.2	0.64	0.58	0.64	0.69
Diluted EPS from Cont Ops	-0.04	0.11	0.06	0.05	0.09	0.13	0.17	0.35	0.31	0.51	1.2	0.64	0.58	0.64	0.69
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.06
Cash Flow per Share	-0.03	-0.01	0.1	0.12	0.21	0.24	0.2	0.34	0.37	0.4	1.11	0.78	0.72	0.68	0.79
Free Cash Flow per Basic Share	-0.03	-0.01	0.1	0.12	0.21	0.24	0.2	0.34	0.37	0.4	1.11	0.62	0.68	0.66	0.74
Cash & Equivalents per Share	0.09	0.05	0.12	0.15	0.17	0.16	0.22	0.43	0.48	0.56	0.87	1.18	1.65	1.37	1.35
Book Value per Share	0.09	0.21	0.33	0.41	0.58	0.7	0.95	1.34	1.67	1.71	2.87	3.44	3.95	4.45	4.92
Tangible Book Value per Share	0.09	0.21	0.33	0.41	0.58	0.7	0.95	1.34	1.67	1.71	2.87	3.3	3.79	4.28	4.72

Regeneron Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)